193
Views
7
CrossRef citations to date
0
Altmetric
Articles

Evaluation of the skin-sensitizing potential of gold nanoparticles and the impact of established dermal sensitivity on the pulmonary immune response to various forms of gold

, , , , &
Pages 1096-1117 | Received 06 Apr 2020, Accepted 09 Jun 2020, Published online: 10 Sep 2020

References

  • Aaron, S., P. Davis, and J. Percy. 1985. “Neutropenia Occurring during the Course of Chrysotherapy: A Review of 25 Cases.” The Journal of Rheumatology 12 (5): 897–899.
  • Agarwal, R., S. K. Sharma, and A. N. Malaviya. 1989. “Gold-Induced Hypersensitivity Pneumonitis in a Patient with Rheumatoid Arthritis.” Clinical and Experimental Rheumatology 7 (1): 89–90.
  • American Society for Testing and Materials International. 2002. Standard Test Method for Metal Powder Specific Surface Area by Physical Adsorption. West Conshohocken, PA: ASTM International.
  • Bancos, S., D. L. Stevens, and K. M. Tyner. 2015. “Effect of Silica and Gold Nanoparticles on Macrophage Proliferation, Activation Markers, Cytokine Production, and Phagocytosis in Vitro.” International Journal of Nanomedicine 10: 183–206. doi:10.2147/IJN.S72580.
  • Barreto, E., M. F. Serra, R. V. Dos Santos, C. E. Dos Santos, J. Hickmann, A. C. Cotias, C. R. Pao, S. G. Trindade, V. Schimidt, C. Giacomelli et al. 2015. “Local Administration of Gold Nanoparticles Prevents Pivotal Pathological Changes in Murine Models of Atopic Asthma.” Journal of Biomedical Nanotechnology 11 (6): 1038–1050. doi:10.1166/jbn.2015.2024.
  • Basketter, D., P. Evans, R. Fielder, G. Gerberick, R. Dearman, and I. Kimber. 2002. “Local Lymph Node Assay—Validation, Conduct and Use in Practice.” Food and Chemical Toxicology 40 (5): 593–598. doi:10.1016/S0278-6915(01)00130-2.
  • Basketter, D. A., L. J. Lea, K. J. Cooper, C. A. Ryan, G. F. Gerberick, R. J. Dearman, and I. Kimber. 1999. “Identification of Metal Allergens in the Local Lymph Node Assay.” American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society 10 (4): 207–212. doi:10.1053/AJCD01000207.
  • Bogaert, P., K. G. Tournoy, T. Naessens, and J. Grooten. 2009. “Where Asthma and Hypersensitivity Pneumonitis Meet and Differ: Noneosinophilic Severe Asthma.” The American Journal of Pathology 174 (1): 3–13. doi:10.2353/ajpath.2009.071151.
  • Breton, J., V. Westeel, G. Garnier, and J. Louis. 1993. “Gold Salt-Induced Pneumonia and CD4 Alveolitis.” J Revue de Pneumologie Clinique 49 (1): 27–29.
  • Chen, J. K., and H. P. Lampel. 2015. “Gold Contact Allergy: Clues and Controversies.” Dermatitis: Contact, Atopic, Occupational, Drug 26 (2): 69–77. doi:10.1097/DER.0000000000000101.
  • Chia-Hui, L., S. Shih-Han, C. Yu-Shiun, M. H. Saber, O. Andrei Aleksandrovich, C. Wen Liang, and G. S. Huang. 2014. “Gold Nanoparticles Regulate the blimp1/pax5 Pathway and Enhance Antibody Secretion in B-Cells.” Nanotechnology 25 (12): 125103.
  • Christiansen, J., G. Farm, R. Eid-Forest, C. Anderson, K. Cederbrant, and P. Hultman. 2006. “Interferon-Gamma Secreted from Peripheral Blood Mononuclear Cells as a Possible Diagnostic Marker for Allergic Contact Dermatitis to Gold.” Contact Dermatitis 55 (2): 101–112. doi:10.1111/j.1600-0536.2006.00908.x.
  • Davis, M. D. P., M. Z. Wang, J. A. Yiannias, J. H. Keeling, S. M. Connolly, D. M. Richardson, and S. A. Farmer. 2011. “Patch Testing with a Large Series of Metal Allergens: Findings from More than 1,000 Patients in One Decade at Mayo Clinic.” Dermatitis 22 (5): 256–271.
  • Dearman, R., D. Basketter, and I. Kimber. 1999. “Local Lymph Node Assay: Use in Hazard and Risk Assessment.” Journal of Applied Toxicology 19 (5): 299–306. doi:10.1002/(SICI)1099-1263(199909/10)19:5<299::AID-JAT591>3.0.CO;2-C.
  • Dreaden, E. C., L. A. Austin, M. A. Mackey, and M. A. El-Sayed. 2012. “Size Matters: Gold Nanoparticles in Targeted Cancer Drug Delivery.” Therapeutic Delivery 3 (4): 457–478. doi:10.4155/tde.12.21.
  • Dykman, L. A., S. A. Staroverov, A. S. Fomin, V. A. Khanadeev, B. N. Khlebtsov, and V. A. Bogatyrev. 2018. “Gold Nanoparticles as an Adjuvant: Influence of Size, Shape, and Technique of Combination with CpG on Antibody Production.” International Immunopharmacology 54: 163–168. doi:10.1016/j.intimp.2017.11.008.
  • Eisler, R. 2003. “Chrysotherapy: A Synoptic Review.” Inflammation Research 52 (12): 487–501. doi:10.1007/s00011-003-1208-2.
  • Evans, D. E., L. A. Turkevich, C. T. Roettgers, G. J. Deye, and P. A. Baron. 2013. “Dustiness of Fine and Nanoscale Powders.” The Annals of Occupational Hygiene 57 (2): 261–277. doi:10.1093/annhyg/mes060.
  • Evans, R. B., D. B. Ettensohn, F. Fawaz-Estrup, E. V. Lally, and S. R. Kaplan. 1987. “Gold Lung: Recent Developments in Pathogenesis, Diagnosis, and Therapy.” Seminars in Arthritis and Rheumatism 16 (3): 196–205. doi:10.1016/0049-0172(87)90022-9.
  • Fowler, J., Jr., J. Taylor, F. Storrs, E. Sherertz, R. Rietschel, M. Pratt, C. G. Mathias, J. Marks, H. Maibach, A. Fransway, et al. 2001. “Gold Allergy in North America.” American Journal of Contact Dermatitis 12 (1): 3–5.
  • Fowler, J. F. 1987. “Selection of Patch Test Materials for Gold Allergy.” Contact Dermatitis 17 (1): 23–25. doi:10.1111/j.1600-0536.1987.tb02639.x.
  • Garcia, J. G., A. Munim, K. M. Nugent, M. Bishop, P. Hoie-Garcia, N. Parhami, and B. A. Keogh. 1987. “Alveolar Macrophage Gold Retention in Rheumatoid Arthritis.” The Journal of Rheumatology 14 (3): 435–438.
  • Garner, L. A. 2004. “Contact Dermatitis to Metals.” Dermatologic Therapy 17 (4): 321–327. doi:10.1111/j.1396-0296.2004.04034.x.
  • Gosens, I., J. A. Post, L. J. de la Fonteyne, E. H. Jansen, J. W. Geus, F. R. Cassee, and W. H. de Jong. 2010. “Impact of Agglomeration State of nano- and submicron sized gold particles on pulmonary inflammation.” Particle and Fibre Toxicology 7 (1): 37. doi:10.1186/1743-8977-7-37.
  • Guo, J., K. Rahme, Y. He, L.-L. Li, J. D. Holmes, and C. M. O’Driscoll. 2017. “Gold Nanoparticles Enlighten the Future of Cancer theranostics.” International Journal of Nanomedicine 12: 6131–6152. doi:10.2147/IJN.S140772.
  • Han, S. G., J. S. Lee, K. Ahn, Y. S. Kim, J. K. Kim, J. H. Lee, J. H. Shin, K. S. Jeon, W. S. Cho, N. W. Song, et al. 2015. “Size-Dependent Clearance of Gold Nanoparticles from Lungs of Sprague-Dawley Rats after Short-Term Inhalation Exposure.” Archives of Toxicology 89 (7): 1083–1094. doi:10.1007/s00204-014-1292-9.
  • Hashizume, H., N. Seo, T. Ito, M. Takigawa, and H. Yagi. 2008. “Promiscuous Interaction between Gold-Specific T Cells and APCs in Gold Allergy.” Journal of Immunology 181 (11): 8096–8102. doi:10.4049/jimmunol.181.11.8096.
  • Highton, J., G. S. Panayi, P. Shepherd, J. Griffin, and T. Gibson. 1981. “Changes in Immune Function in Patients with Rheumatoid Arthritis following Treatment with Sodium Aurothiomalate.” Annals of the Rheumatic Diseases 40 (3): 254–262. doi:10.1136/ard.40.3.254.
  • Hunter, T. 1985. “Hypogammaglobulinaemia Associated with Gold Therapy.” Annals of the Rheumatic Diseases 44 (3): 212. doi:10.1136/ard.44.3.212-a.
  • Hussain, S., J. A. J. Vanoirbeek, K. Luyts, V. De Vooght, E. Verbeken, L. C. J. Thomassen, J. A. Martens, D. Dinsdale, S. Boland, F. Marano, et al. 2011. “Lung Exposure to Nanoparticles Modulates an Asthmatic Response in a Mouse model.” European Respiratory Journal 37 (2): 299–309. doi:10.1183/09031936.00168509.
  • Ikarashi, Y., M. Kaniwa, and T. Tsuchiya. 2002. “Sensitization Potential of Gold Sodium Thiosulfate in Mice and guinea Pigs.” Biomaterials 23 (24): 4907–4914. doi:10.1016/s0142-9612(02)00250-8.
  • Karlberg, A. T., M. A. Bergstrom, A. Borje, K. Luthman, and J. L. Nilsson. 2008. “Allergic Contact dermatitis-formation, structural requirements, and reactivity of skin sensitizers.” Chemical Research in Toxicology 21 (1): 53–69. doi:10.1021/tx7002239.
  • Kaur, S., M. Eisen, K. Leiger, and K. Injarabian. 2006. “Screening for Gold Allergy among Dental Clinic Employees and Patch Test Population.” Contact Dermatitis 54 (3): 172–173. doi:10.1111/j.0105-1873.2006.0739e.x.
  • Kim, J. S., K. S. Song, J. H. Sung, H. R. Ryu, B. G. Choi, H. S. Cho, J. K. Lee, and I. J. Yu. 2013. “Genotoxicity, Acute Oral and Dermal Toxicity, Eye and Dermal Irritation and Corrosion and Skin Sensitisation Evaluation of Silver Nanoparticles.” Nanotoxicology 7 (5): 953–960. doi:10.3109/17435390.2012.676099.
  • Kubo, M. 2017. “Innate and Adaptive Type 2 Immunity in Lung Allergic Inflammation.” Immunological Reviews 278 (1): 162–172. doi:10.1111/imr.12557.
  • Kumar, P., and I. Roy. 2016. “Applications of Gold Nanoparticles in Clinical Medicine.” International Journal of Pharmacy and Pharmaceutical Sciences 8 (7): 9–16.
  • Larsen, F. S., and F. Brandrup. 1980. “Nickel Release from Metallic Buttons in Blue Jeans.” Contact Dermatitis 6 (4): 298–299.
  • Licona-Limón, P., L. K. Kim, N. W. Palm, and R. A. Flavell. 2013. “TH2, Allergy and Group 2 Innate Lymphoid Cells.” Nature Immunology 14 (6): 536–542. doi:10.1038/ni.2617.
  • Liden, C., M. Nordenadler, and L. Skare. 1998. “Metal Release from Gold-Containing Jewelry Materials: No Gold Release Detected.” Contact Dermatitis 39 (6): 281–285. doi:10.1111/j.1600-0536.1998.tb05942.x.
  • Matsumura, Y., A. Miyake, and T. Ishida. 1992. “A case of gold lung with positive lymphocyte stimulation test to gold, using bronchoalveolar lymphocytes.” Nihon Kyobu Shikkan Gakkai Zasshi 30 (3): 472–477.
  • McCormick, J., S. Cole, B. Lahirir, F. Knauft, S. Cohen, and T. Yoshida. 1980. “Pneumonitis Caused by Gold Salt Therapy: Evidence for the Role of Cell-Mediated Immunity in Its Pathogenesis.” The American Review of Respiratory Disease 122 (1): 145–152. doi:10.1164/arrd.1980.122.1.145.
  • McKenzie, A. N. 2014. “Type-2 Innate Lymphoid Cells in Asthma and Allergy.” Annals of the American Thoracic Society 11 (5): S263–S270. doi:10.1513/AnnalsATS.201403-097AW.
  • Minang, J. T., I. Arestrom, M. Troye-Blomberg, L. Lundeberg, and N. Ahlborg. 2006. “Nickel, Cobalt, Chromium, Palladium and Gold Induce a Mixed Th1- and Th2-Type Cytokine Response in Vitro in Subjects with Contact Allergy to the Respective Metals.” Clinical and Experimental Immunology 146 (3): 417–426. doi:10.1111/j.1365-2249.2006.03226.x.
  • Misharin, A. V., L. Morales-Nebreda, G. M. Mutlu, G. R. S. Budinger, and H. Perlman. 2013. “Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung.” American Journal of Respiratory Cell and Molecular Biology 49 (4): 503–510. doi:10.1165/rcmb.2013-0086MA.
  • Moller, H., I. Ahnlide, B. Gruvberger, and M. Bruze. 2005. “Gold Trichloride and Gold Sodium Thiosulfate as Markers of Contact Allergy to Gold.” Contact Dermatitis 53 (2): 80–83. doi:10.1111/j.0105-1873.2005.00648.x.
  • National Institute of Standards Technology (NIST). 2015. Report of Investigation: Reference Material 8012- Gold Nanoparticles, Nominal 30 nm Diameter.
  • Paako, P., S. Anttila, S. Sutinen, and M. Hakala. 1984. “Lysosomal Gold Accumulations in Pulmonary Macrophages.” Ultrastructural Pathology 7 (4): 289–294. doi:10.3109/01913128409141489.
  • Piasecka-Zelga, J., P. Zelga, M. Górnicz, P. Strzelczyk, and J. Sójka-Ledakowicz. 2015. “Acute Dermal Toxicity and Sensitization Studies of Novel Nano-Enhanced UV Absorbers.” Journal of Occupational Health 57 (3): 275–284. doi:10.1539/joh.14-0207-OA.
  • Roach, K. A., A. B. Stefaniak, and J. R. Roberts. 2019. “Metal Nanomaterials: Immune Effects and Implications of Physicochemical Properties on Sensitization, Elicitation, and Exacerbation of Allergic Disease.” Journal of Immunotoxicology 16 (1): 87–124. doi:10.1080/1547691X.2019.1605553.
  • Romagnani, S. 2004. “Immunologic Influences on Allergy and the TH1/TH2 Balance.” The Journal of Allergy and Clinical Immunology 113 (3): 395–400. doi:10.1016/j.jaci.2003.11.025.
  • Schulz, M., L. Ma-Hock, S. Brill, V. Strauss, S. Treumann, S. Gröters, B. van Ravenzwaay, and R. Landsiedel. 2012. “Investigation on the Genotoxicity of Different Sizes of Gold Nanoparticles Administered to the Lungs of Rats.” Mutation Research/Genetic Toxicology and Environmental Mutagenesis 745 (1–2): 51–57. doi:10.1016/j.mrgentox.2011.11.016.
  • Seydoux, E., L. Rodriguez-Lorenzo, R. A. M. Blom, P. A. Stumbles, A. Petri-Fink, B. M. Rothen-Rutishauser, F. Blank, and C. von Garnier. 2016. “Pulmonary Delivery of Cationic Gold Nanoparticles Boost Antigen-Specific CD4+ T Cell Proliferation.” Nanomedicine: Nanotechnology, Biology, and Medicine 12 (7): 1815–1826. doi:10.1016/j.nano.2016.02.020.
  • Sforza, G. G. R., and A. J. C. Marinou. 2017. “Hypersensitivity Pneumonitis: A Complex Lung Disease.” Clinical and Molecular Allergy 15 (1): 6.
  • Thakor, A. S., J. Jokerst, C. Zavaleta, T. F. Massoud, and S. S. Gambhir. 2011. “Gold Nanoparticles: A Revival in Precious Metal Administration to Patients.” Nano Letters 11 (10): 4029–4036. doi:10.1021/nl202559p.
  • Tomioka, R., and T. E. King. 1997. “Gold-Induced Pulmonary Disease: Clinical Features, Outcome, and Differentiation from Rheumatoid Lung Disease.” American Journal of Respiratory and Critical Care Medicine 155 (3): 1011–1020. doi:10.1164/ajrccm.155.3.9116980.
  • Wang, Y., and S. Dai. 2013. “Structural Basis of Metal Hypersensitivity.” Immunologic Research 55 (1-3): 83–90. doi:10.1007/s12026-012-8351-1.
  • Yamada, M., M. Foote, and T. W. Prow. 2015. “Therapeutic Gold, Silver, and Platinum Nanoparticles.” Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology 7 (3): 428–445. doi:10.1002/wnan.1322.
  • Yanez-Sedeno, P., and J. Pingarron. 2005. “Gold Nanoparticle-Based Electrochemical Biosensors.” J Analytical Bioanalytical Chemistry 382 (4): 884–886.
  • Yoshioka, Y., E. Kuroda, T. Hirai, Y. Tsutsumi, and K. J. Ishii. 2017. “Allergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin Exposure.” Frontiers in Immunology 8: 169. doi:10.3389/fimmu.2017.00169.
  • Zhang, Q., N. Iwakuma, P. Sharma, B. Moudgil, C. Wu, J. McNeill, H. Jiang, and S. Grobmyer. 2009. “Gold Nanoparticles as a Contrast Agent for in Vivo Tumor Imaging with Photoacoustic Tomography.” Nanotechnology 20 (39): 395102. doi:10.1088/0957-4484/20/39/395102.
  • Zhang, Y., T. P. Shareena Dasari, H. Deng, and H. Yu. 2015. “Antimicrobial Activity of Gold Nanoparticles and Ionic Gold.” Journal of Environment Science and Health. Part C Environmental Carcinogenesis & Ecotoxicology Reviews 33 (3): 286–327. doi:10.1080/10590501.2015.1055161.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.